Osteoporosis in end-state renal disease

Area of Science:

• Nephrology
• Endocrinology
• Orthopedics

Background:

• Chronic renal failure (CRF) and renal osteodystrophy disrupt bone mineral homeostasis.
• Patients with end-stage renal disease (ESRD) exhibit high-turnover bone disease (secondary hyperparathyroidism) and low-turnover bone disease (osteomalacia).
• Osteopenia, a deficiency in bone mass, is also prevalent in ESRD patients, distinct from bone remodeling abnormalities.

Purpose of the Study:

• To elucidate the multifaceted nature of bone disease in chronic renal failure.
• To highlight the contributing factors to osteopenia in dialysis patients.
• To underscore the elevated fracture risk associated with renal osteodystrophy and osteopenia.

Main Methods:

• Review of existing literature on bone mineral metabolism in chronic renal failure.
• Analysis of factors contributing to bone loss in dialysis patients.
• Comparison of fracture prevalence in dialysis patients versus other populations.

Main Results:

• CRF patients present with complex bone pathologies including secondary hyperparathyroidism, osteomalacia, and osteopenia.
• Osteopenia in dialysis patients results from multiple factors: hypogonadism, medications (e.g., corticosteroids), immobilization, and aging.
• Fracture prevalence in dialysis patients is notably high, exceeding that in elderly women.

Conclusions:

• Bone mineral homeostasis is significantly compromised in chronic renal failure and renal osteodystrophy.
• Osteopenia is a critical component of bone disease in ESRD, amplifying fracture risk.
• A comprehensive approach is needed to manage bone health and reduce fractures in dialysis patients.